Treace Medical Concepts Files 8-K

Ticker: TMCI · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1630627

Treace Medical Concepts, Inc. 8-K Filing Summary
FieldDetail
CompanyTreace Medical Concepts, Inc. (TMCI)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-update, sec-filing

Related Tickers: TMCI

TL;DR

TREACE MEDICAL CONCEPTS (TMCI) filed an 8-K on Jan 13, 2025, updating corporate info. Stock trades on Nasdaq.

AI Summary

Treace Medical Concepts, Inc. filed an 8-K on January 13, 2025, to report current information. The filing confirms the company's principal executive offices are located at 100 Palmetto Park Place, Ponte Vedra, Florida 32081, and its telephone number is (904) 373-5940. The company's common stock trades on The Nasdaq Global Select Market under the symbol TMCI.

Why It Matters

This 8-K filing serves as a notification of corporate information updates for Treace Medical Concepts, Inc., relevant for investors tracking the company's operational details.

Risk Assessment

Risk Level: low — This filing is a routine corporate update and does not contain material financial or operational news that would inherently increase risk.

Key Players & Entities

  • TREACE MEDICAL CONCEPTS, Inc. (company) — Registrant
  • January 13, 2025 (date) — Date of earliest event reported
  • 100 Palmetto Park Place, Ponte Vedra, Florida 32081 (location) — Address of principal executive offices
  • (904) 373-5940 (phone_number) — Registrant's telephone number
  • TMCI (ticker) — Trading Symbol for Common Stock
  • The Nasdaq Global Select Market (exchange) — Name of exchange where common stock is registered

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report current information as required by the Securities and Exchange Commission, specifically updating corporate details for Treace Medical Concepts, Inc.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on January 13, 2025.

Where are Treace Medical Concepts, Inc.'s principal executive offices located?

Treace Medical Concepts, Inc.'s principal executive offices are located at 100 Palmetto Park Place, Ponte Vedra, Florida 32081.

What is the trading symbol for Treace Medical Concepts, Inc.'s common stock?

The trading symbol for Treace Medical Concepts, Inc.'s common stock is TMCI.

On which exchange is Treace Medical Concepts, Inc.'s common stock registered?

Treace Medical Concepts, Inc.'s common stock is registered on The Nasdaq Global Select Market.

Filing Stats: 710 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2025-01-13 08:05:14

Key Financial Figures

  • $0.001 — nge on which registered Common Stock, $0.001 par value per share TMCI The Nasdaq

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 13, 2025, Treace Medical Concepts, Inc. ("the Company") issued a press release regarding certain preliminary unaudited financial results for the quarter and the year-ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K. This information furnished under Item 2.02 of Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On January 13, 2025, Treace Medical Concepts, Inc. posted an investor presentation, which may be accessed through the Company's investor relations website. A copy of the presentation is furnished herewith as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. The Company intends to use this presentation in meetings with analysts, investors and others from time to time, including its presentation by management at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 9:00 am Pacific Time / 12:00 pm Eastern Time. A live webcast of this event, as well as an archived recording and presentation, will be available in the Investors section of the Company's website. The information furnished under this Item 7.01, including Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release of Treace Medical Concepts, Inc. issued on January 13, 2025 99.2 Investor Presentation, dated January 13, 2025 (furnished pursuant to Item 7.01) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TREACE MEDICAL CONCEPTS, INC. Date: January 13, 2025 By: /s/ Mark L. Hair Mark L. Hair Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.